Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | GV20-0251 |
Synonyms | |
Therapy Description |
Limited information is currently available on GV20-0251, a putative IGSF8 antibody (May 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GV20-0251 | GV20 0251|GV200251 | Limited information is currently available on GV20-0251, a putative IGSF8 antibody (May 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05669430 | Phase I | GV20-0251 | A Study of GV20-0251 in Patients With Solid Tumor Malignancies | Recruiting | USA | 0 |